| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.051 | 0.8 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | 0.045 | 0.8 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.0094 | 0.8 |